IMC‐383/NCT00913835.
Trial name or title | A study of liposomal doxorubicin with or without IMC‐3G3 in platinum‐refractory or resistant advanced ovarian cancer |
Methods | Phase II open‐label RCT |
Participants | 125 women with ROC |
Interventions | IMC‐383 + LD versus LD |
Outcomes | Primary: PFS Secondary: OS, ORR, duration of response, SAE |
Starting date | Jun 2009 |
Contact information | ClinicalTrials@ ImClone.com |
Notes | End Date: Oct 2011 |